High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia. | Chest;160(1): e94-e95, 2021 07. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia.

Nadeem, Rashid; Kamat, Sahish.

Nadeem R; Dubai Hospital, Dubai, United Arab Emirates. Electronic address: nadeem.dr@gmail.com.
Kamat S; Dubai Hospital, Dubai, United Arab Emirates.

Chest ; 160(1): e94-e95, 2021 07.

Article in English | MEDLINE | ID: covidwho-1525724

Subject(s)

COVID-19; Anticoagulants/pharmacology; Anticoagulants/therapeutic use; Blood Coagulation/drug effects; Enoxaparin; Humans; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Chest Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Chest Year: 2021 Document Type: Article